These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 303540)

  • 1. Chemotherapy of cell-line-derived human colon carcinomas in mice immunosuppressed with antithymocyte serum.
    Tibbetts LM; Chu MY; Hager JC; Dexter DL; Calabresi P
    Cancer; 1977 Nov; 40(5 Suppl):2651-9. PubMed ID: 303540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy of human colon cancer xenografts in athymic nude mice.
    Osieka R; Houchens DP; Goldin A; Johnson RK
    Cancer; 1977 Nov; 40(5 Suppl):2640-50. PubMed ID: 144557
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of single agents and combinations of chemotherapeutic agents in mouse colon carcinomas.
    Corbett TH; Griswold DP; Roberts BJ; Peckham JC; Schabel FM
    Cancer; 1977 Nov; 40(5 Suppl):2660-80. PubMed ID: 922705
    [No Abstract]   [Full Text] [Related]  

  • 4. Xenografts in pharmacologically immunosuppressed mice as a model to test the chemotherapeutic sensitivity of human tumors.
    Floersheim GL; Bieri A; Chiodetti N
    Int J Cancer; 1986 Jan; 37(1):109-14. PubMed ID: 3455687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor.
    Al Safarjalani ON; Rais R; Shi J; Schinazi RF; Naguib FN; el Kouni MH
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):692-8. PubMed ID: 16528530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a method for assessing the antitumor activity of chemotherapeutic agents using human tumor xenografts.
    Cobb LM; Mitchley BC
    Cancer Chemother Rep; 1974; 58(5 Pt 1):645-51. PubMed ID: 4609597
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy of recombinant methioninase in combination with cisplatin on human colon tumors in nude mice.
    Tan Y; Sun X; Xu M; Tan X; Sasson A; Rashidi B; Han Q; Tan X; Wang X; An Z; Sun FX; Hoffman RM
    Clin Cancer Res; 1999 Aug; 5(8):2157-63. PubMed ID: 10473100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon beta increases antitumor activity of 5-fluorouracil against human colon carcinoma cells in vitro and in vivo.
    Kase S; Kubota T; Watanabe M; Furukawa T; Tanino H; Ishibiki K; Teramoto T; Kitajima M
    Anticancer Res; 1993; 13(2):369-73. PubMed ID: 8517649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of autophagy augments 5-fluorouracil chemotherapy in human colon cancer in vitro and in vivo model.
    Li J; Hou N; Faried A; Tsutsumi S; Kuwano H
    Eur J Cancer; 2010 Jul; 46(10):1900-9. PubMed ID: 20231086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-fluorouracil-based chemotherapy enhances the antitumor activity of a thymidylate synthase-directed polyepitopic peptide vaccine.
    Correale P; Del Vecchio MT; Di Genova G; Savellini GG; La Placa M; Terrosi C; Vestri M; Urso R; Lemonnier F; Aquino A; Bonmassar E; Giorgi G; Francini G; Cusi MG
    J Natl Cancer Inst; 2005 Oct; 97(19):1437-45. PubMed ID: 16204693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The sensitivity to chemotherapeutic agents of a rat tumour grown in immunosuppressed mice.
    Sheard CE; Double JA; Berenbaum MC
    Br J Cancer; 1971 Dec; 25(4):838-44. PubMed ID: 5144544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of drug resistance in human gastric and colon carcinoma xenograft lines.
    Satta T; Isobe K; Yamauchi M; Nakashima I; Akiyama S; Itou K; Watanabe T; Takagi H
    Jpn J Cancer Res; 1991 May; 82(5):593-8. PubMed ID: 1905705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CF101, an agonist to the A3 adenosine receptor, enhances the chemotherapeutic effect of 5-fluorouracil in a colon carcinoma murine model.
    Bar-Yehuda S; Madi L; Silberman D; Gery S; Shkapenuk M; Fishman P
    Neoplasia; 2005 Jan; 7(1):85-90. PubMed ID: 15720820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth of human tumors in mice after short-term immunosuppression with procarbazine, cyclophosphamide, and antilymphocyte serum.
    Floersheim GL; Nassenstein D; Torhorst J
    Transplantation; 1980 Oct; 30(4):275-80. PubMed ID: 6934635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapeutic sensitivity of human colorectal tumor xenografts.
    Kopper L; Lapis K; Hegedüs C
    Oncology; 1980; 37 Suppl 1():42-50. PubMed ID: 7454200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo antitumor activity of hexamethylmelamine against human breast, stomach and colon carcinoma xenografts.
    Tanino H; Kubota T; Yamada Y; Koh J; Kase S; Furukawa T; Kuo TH; Saikawa Y; Kitajima M; Naito Y
    Jpn J Cancer Res; 1995 Aug; 86(8):770-5. PubMed ID: 7559101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human insulin-like growth factor-binding protein 3 inhibits tumor growth and targets the Akt pathway in lung and colon cancer models.
    Alami N; Page V; Yu Q; Jerome L; Paterson J; Shiry L; Leyland-Jones B
    Growth Horm IGF Res; 2008 Dec; 18(6):487-96. PubMed ID: 18502161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative growth of human tumors in pharmacologically immunosuppressed, immune-deprived, cyclosporin A-treated and nude mice.
    Floersheim GL
    Eur J Cancer Clin Oncol; 1982 Jun; 18(6):589-94. PubMed ID: 6749512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The therapeutic response of three human tumor lines maintained in immune-suppressed mice.
    Kopper L; Steel GG
    Cancer Res; 1975 Oct; 35(10):2704-13. PubMed ID: 1157045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel combination antimetabolite, TAS-102, exhibits antitumor activity in FU-resistant human cancer cells through a mechanism involving FTD incorporation in DNA.
    Emura T; Suzuki N; Yamaguchi M; Ohshimo H; Fukushima M
    Int J Oncol; 2004 Sep; 25(3):571-8. PubMed ID: 15289858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.